scispace - formally typeset
F

Franco Placa

Researcher at University of Milan

Publications -  10
Citations -  1778

Franco Placa is an academic researcher from University of Milan. The author has contributed to research in topics: Cervical cancer & Survival rate. The author has an hindex of 7, co-authored 10 publications receiving 1618 citations.

Papers
More filters
Journal ArticleDOI

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

TL;DR: There is no treatment of choice for early-stage cervical carcinoma in terms of overall or disease-free survival and the combination of surgery and radiotherapy has the worst morbidity, especially urological complications.
Journal ArticleDOI

Concurrent Preoperative Chemotherapy with 5-Fluorouracil and Mitomycin C and Radiotherapy (FUMIR) Followed by Limited Surgery in Locally Advanced and Recurrent Vulvar Carcinoma

TL;DR: This treatment allows good control of locally advanced and recurrent vulvar cancer with acceptable side effects and further follow-up is required to determine the long-term outcome and the effectiveness of the surgical procedure.
Journal ArticleDOI

Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update

TL;DR: The results of the present study seem to suggest that there is no treatment of choice for early stage cervical carcinoma in terms of survival and long term follow-up confirms that the best treatment for the individual patient should take into account clinical factors such as menopausal status, comorbidities, histological type, and tumor diameter.
Journal ArticleDOI

Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma

TL;DR: The acceptable toxicity, high response rate and satisfying survival would suggest that concomitant carboplatin/5-fluorouracil and radiotherapy is a safe and tolerable treatment for recurrent cervical carcinoma.
Journal ArticleDOI

HIV infection and invasive cervical carcinoma in an Italian population: the need for closer screening programmes in seropositive patients.

TL;DR: It is confirmed that in a southern European population, HIV- seropositive women present to tertiary-care institutions with more advanced disease, and have a poorer prognosis than the general population.